Prognostic Role of Embolic Burden Assessed at Computed Tomography Angiography in Patients with Acute Pulmonary Embolism: Systematic Review and Meta-analysis
Overview
Authors
Affiliations
Background: In patients with acute pulmonary embolism (PE), risk stratification is indicated for tailoring of both diagnostic strategies and acute treatment. Whether embolic burden assessed at computed tomography (CT) angiography has a role in risk stratification in these patients is debated.
Objective: To systematically review and perform a meta-analysis to evaluate the role of CT-assessed burden associated with embolic obstruction and embolic localization in the prognostic stratification of patients with acute PE.
Methods: We performed a systematic search in EMBASE and MEDLINE up until 30 June 2013. Studies reporting on the 30-day outcome of patients with confirmed PE and CT-assessed embolic burden were included. The study outcome was death.
Results: Thirty studies reporting on the prognostic value of CT-assessed embolic burden met the inclusion criteria for this systematic review; of these, 19 were included in the meta-analysis. Five studies (2215 patients) were included in the analysis of localization: an association between embolus localization in the central arteries and 30-day mortality was found after heterogeneity was resolved (odds ratio [OR] 2.24, 95% confidence interval [CI] 1.29-3.89, I(2) = 0%). No correlation was observed between obstruction index (according to the Qanadli scoring system) and 30-day mortality after heterogeneity was reduced (16 studies, 3884 patients, OR 1.22, 95% CI 0.99-1.51, I(2) = 27%).
Conclusion: Localization of emboli assessed at CT angiography can be used for risk stratification in patients with acute PE. Moreover, no correlation was observed between obstruction index and prognosis.
Al-Dorzi H, Almutawa F, AlRuhaymi B, Alhusaini A, Alnamlah A, Shaman A Thromb J. 2025; 23(1):22.
PMID: 40087650 DOI: 10.1186/s12959-025-00708-w.
Comparison of Qanadli score with conventional risk stratifiers in non-massive pulmonary emboli.
Hajsadeghi S, Shamsedini A, Bahadoran P, Amouei E, Mirshafiee S J Int Med Res. 2024; 52(9):3000605241276481.
PMID: 39301817 PMC: 11418528. DOI: 10.1177/03000605241276481.
Lyhne M, Schultz J, Mortensen C, Kramer A, Nielsen-Kudsk J, Andersen A BMC Pulm Med. 2024; 24(1):233.
PMID: 38745282 PMC: 11093735. DOI: 10.1186/s12890-024-03006-9.
Othman M, Yusof Z, Ismail Z, Sayuti K, W Isa W Cureus. 2024; 16(1):e52889.
PMID: 38274596 PMC: 10808894. DOI: 10.7759/cureus.52889.
Xi L, Xu F, Kang H, Deng M, Xu W, Wang D Quant Imaging Med Surg. 2024; 14(1):86-97.
PMID: 38223063 PMC: 10784004. DOI: 10.21037/qims-23-322.